Association between the Expression of KISS1, KISS1R and MMP-9 in Invasive Breast Carcinomas

Authors

  • Despina Pupaki Institute of Biology and Immunology of Reproduction, Bulgarian Academy of Sciences
  • Svitlana Bachurska Clinic of Pathology, National Oncology Hospital – Sofia, Bulgaria
  • Dimitar Parvanov Nadezhda Women’s Health Hospital, Bulgaria
  • Dessislava Ankova Institute of Biology and Immunology of Reproduction, Bulgarian Academy of Sciences
  • Pavel Rashev Institute of Biology and Immunology of Reproduction, Bulgarian Academy of Sciences

DOI:

https://doi.org/10.7546/CRABS.2022.10.15

Keywords:

KISS1, KISS1R, MMP-9, metastasis promoter, invasive breast carcinomas

Abstract

 Metastases are the leading cause of fatal outcome in patients with breast cancer, therefore different proteins related to metastasis are widely studied for the potential to control the spread of cancer cells. It has been shown in various types of cancers that the anti-metastatic role of the KISS1/KISS1R system has been performed by suppressing metalloproteinase 9 (MMP-9) expression, but there is evidence that the relationship between KISS1/KISS1R signalling and MMP-9 in breast cancer seems to be different. The aim of the current study was to assess the association between protein expression of KISS1, KISS1R and MMP-9 using software-based measurement of staining intensity and the possible link to tumour size, grade and receptor status in invasive breast carcinomas. Standard histopathological parameters were determined by an experienced pathologist and immunohistochemical staining for KISS1, KISS1R and MMP-9 was performed on tissue samples from 54 patients. Evaluation of staining intensity was performed using ImageJ software on RGB images by two operators. Results showed significant strong positive correlation between KISS1, KISS1R and MMP-9 and strong expression of studied proteins in tumour associated stromal cells. No association was found between the expression of the studied proteins and size, receptor status or grade. Higher expression of KISS1R, however, was observed in HER2-negative compared to HER2-positive carcinomas, which might indicate an alternative pathway for stimulating pro- proliferation of tumour cells when HER2 expression is low.

Author Biographies

Despina Pupaki, Institute of Biology and Immunology of Reproduction, Bulgarian Academy of Sciences

Mailing Address:
Institute of Biology and Immunology of Reproduction “Akad. Kiril Bratanov”,
Bulgarian Academy of Sciences
73 Tsarigradsko Shosse Blvd
1113 Sofia, Bulgaria

E-mails: poupaki_desi@abv.bg

Svitlana Bachurska, Clinic of Pathology, National Oncology Hospital – Sofia, Bulgaria

Mailing Address:
Clinic of Pathology,
National Oncology Hospital – Sofia
6 Plovdivsko Pole St
1756 Sofia, Bulgaria

E-mail: svitba@gmail.com

Dimitar Parvanov, Nadezhda Women’s Health Hospital, Bulgaria

Mailing Address:
Nadezhda Women’s Health Hospital
3 Blaga Vest St
1330 Sofia, Bulgaria

E-mail: dimparvanov@abv.bg

Dessislava Ankova, Institute of Biology and Immunology of Reproduction, Bulgarian Academy of Sciences

Mailing Address:
Institute of Biology and Immunology of Reproduction “Akad. Kiril Bratanov”,
Bulgarian Academy of Sciences
73 Tsarigradsko Shosse Blvd
1113 Sofia, Bulgaria

E-mails: dessislava_ankova@abv.bg

Pavel Rashev, Institute of Biology and Immunology of Reproduction, Bulgarian Academy of Sciences

Mailing Address:
Institute of Biology and Immunology of Reproduction “Akad. Kiril Bratanov”,
Bulgarian Academy of Sciences
73 Tsarigradsko Shosse Blvd
1113 Sofia, Bulgaria

E-mails: pavel_rashev@abv.bg

Downloads

Published

30-10-2022

How to Cite

[1]
D. Pupaki, S. Bachurska, D. Parvanov, D. Ankova, and P. Rashev, “Association between the Expression of KISS1, KISS1R and MMP-9 in Invasive Breast Carcinomas”, C. R. Acad. Bulg. Sci., vol. 75, no. 10, pp. 1514–1521, Oct. 2022.

Issue

Section

Medicine